Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis.
about
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerAnticoagulation for the initial treatment of venous thromboembolism in patients with cancerHome versus in-patient treatment for deep vein thrombosisLow-molecular-weight heparins in the treatment of venous thromboembolismDosing and monitoring of low-molecular-weight heparins in special populations.Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy.Low molecular weight heparin-induced skin necrosis-a systematic review.Low molecular weight heparins and coronary artery disease.Differentiation of the low-molecular-weight heparins.Home versus in-patient treatment for deep vein thrombosis.Low molecular weight heparin(s).The use of low molecular weight heparin in the initial management of patients with deep vein thrombosis.Medical management of patients with an acute stroke: treatment and prevention.Ancrod for coronary angioplasty.Treatment of venous thromboembolism: challenging the unfractionated heparin standard.Low molecular weight heparin in pregnancy: current issues.Low molecular weight heparin in acute stroke.Some limits to evidence-based medicine: a case study from elective orthopaedicsManagement of venous thromboembolism in patients with cancer: role of dalteparin.Use of the PFA-100 closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: a systematic review and meta-analysis.The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.Stroke treatment: beyond the three-hour window and in the pregnant patient.Contemporary management of pulmonary embolism: the answers to ten questions.Current anticoagulant safety.A randomised controlled trial of the costs of hospital as compared with hospital in the home for acute medical patients.How do palliative physicians manage venous thromboembolism?Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis.Low-molecular-weight heparin for venous thromboembolism.Developments in antithrombotic therapy: state of the art anno 1996.Low-molecular-weight heparins for acute coronary syndromes.Low-molecular-weight heparins in the treatment of pulmonary embolism.Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosisHospital versus home treatment of deep vein thrombosis in a tertiary care hospital in Saudi Arabia: Are we ready?Possible benefits of low molecular weight heparinsAvoiding the consequences of deep vein thrombosis. Elevation and compression are important-and too often forgotten.Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins.Low-molecular-weight heparin in pregnancy: peripartum bleeding complications.
P2860
Q24193871-3BDFCEA1-C466-4928-B473-45FC596DD338Q24234155-DCFFCF4A-2629-4AC1-AC40-056FA0351303Q24235193-C6D9DEA8-E07B-43B4-83B9-FB650CBACAC2Q24236443-D3CB6E69-6EAC-4DE6-B8A7-5F430EAB8E70Q24242243-0F9CE6F1-B8B9-41E6-974A-CF3704E177BDQ24244051-4489CF29-79A6-4434-A9DE-109BBFF45CB4Q24792692-9EEDB197-DB16-49A4-9DF8-EABFC4E91ED1Q32049893-EACBE438-2ECA-4E71-82D8-F23D6040CEFFQ33360869-2C953F3C-8903-49D5-84B1-83589E39A043Q33363909-318D3A04-5C91-4AA4-BFF2-8FE9CDA47D38Q34027403-8F59C401-39AE-46C4-B416-AE3FE87D2D5BQ34278856-E1ABB14B-B186-4BE0-AFC1-281576543ABEQ34282061-F98621EE-E170-42DE-8D3D-C255410C19D3Q34313459-37550F36-4E10-4E4C-8C67-22A1BCDCD395Q34585924-2F284BF1-A1FB-4251-A031-EADE0D5ECD14Q35610113-D5BAFA23-1411-44B0-A584-F137878C63A1Q35657450-DBBFCB80-1EE7-4576-A24E-8026C25CC757Q35873521-47DFA1D9-8F7A-410D-ADCB-153CA76999F7Q36051434-CF87A00F-D4CB-46CB-93AF-3151F1E55349Q36181238-63674188-5E3F-406B-AECF-FD93EC662E0DQ36790943-9E669E3C-61F1-4551-8016-66DCAEC531DFQ36812767-111CB744-C07B-41BF-B6DE-C5E91B1E3DD4Q37056745-64BFBD7C-84DF-49D7-BB8E-F73AE633F537Q37316352-1B117E0B-7C56-455B-97DE-C457FFFCF59DQ37319657-57AAC8E7-8071-4418-ABB2-FFD9D969AAF5Q37772211-C12CE215-55BD-4E71-AA6E-14D1475C6802Q37990564-2A8BC0B7-9FD8-4F0B-B77C-ED67E86E4C75Q38473499-443485DA-8D77-4D1D-A68C-1ACBFE7275B0Q39227063-3B26037D-1A4E-4AA7-ACF8-A547DD62D11EQ41245830-A901746B-9A1E-4BBE-88EF-965EECD15648Q41327691-9EAD20E6-0727-45BF-811D-41B838643F02Q41332329-D594193E-DBC5-45D5-B6E0-06644B935133Q41707230-EE61D7D7-AFA4-4F3F-A768-76727A9B205CQ41718764-B7AA206F-FFEA-4CF9-8085-2D8DB58DED0EQ41821940-1FE2A967-3A34-45A8-8275-F4A4D578B2BFQ42557127-AEBB933A-1A7C-4EFA-9EA3-5512E33148E3Q42613071-BF77B4BB-5BF0-4250-B2D3-EDAEB7747FBBQ42758405-864E135E-90F1-4FFF-9A2E-0FF8F9F782D9Q42996525-B580A4C4-1942-4B6B-A19A-7C9EC2FFC98EQ46339567-0DECEFB8-741E-4AEC-8E28-50AB2D77739C
P2860
Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Comparison of efficacy and saf ...... s thrombosis: a meta-analysis.
@en
Comparison of efficacy and saf ...... s thrombosis: a meta-analysis.
@nl
type
label
Comparison of efficacy and saf ...... s thrombosis: a meta-analysis.
@en
Comparison of efficacy and saf ...... s thrombosis: a meta-analysis.
@nl
prefLabel
Comparison of efficacy and saf ...... s thrombosis: a meta-analysis.
@en
Comparison of efficacy and saf ...... s thrombosis: a meta-analysis.
@nl
P2093
P2860
P356
P1433
P1476
Comparison of efficacy and saf ...... s thrombosis: a meta-analysis.
@en
P2093
Boissel JP
Decousus H
Leizorovicz A
Simonneau G
P2860
P304
P356
10.1136/BMJ.309.6950.299
P407
P577
1994-07-01T00:00:00Z